awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48226075-10AC6333-3022-44AB-86F6-BA5C1EFC0D40
Q48226075-10AC6333-3022-44AB-86F6-BA5C1EFC0D40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48226075-10AC6333-3022-44AB-86F6-BA5C1EFC0D40
Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies: results from a systematic review and meta-analysis of randomized controlled trial.
P2860
Q48226075-10AC6333-3022-44AB-86F6-BA5C1EFC0D40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48226075-10AC6333-3022-44AB-86F6-BA5C1EFC0D40
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
61fb4aa362be0c4bcc82e338b0bd20a63933103e
P2860
Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer.